-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tenecteplase in Acute Respiratory Failure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tenecteplase in Acute Respiratory Failure report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tenecteplase in Acute Respiratory Failure Drug Details: Tenecteplase (Metalyse, Tnkase)...
-
Analyst Opinions
NewFactors of Influence for Purchases – Key Trends and Consumer Insights
Factors of Influence for Purchases – Key Trends and Consumer Insights Report Overview The top five factors that influence consumers’ purchases are value for money, quality, price, discounts and promotions, and range. Value for money is the most influential factor among others for most sectors. This is unsurprising given the persistent pressures on consumers’ discretionary incomes and weak consumer confidence. On the other hand, discounts and promotions are generally less influential in purchasing choices but this is relatively more important...
-
Sector Analysis
NewInstore Shopping – Key Trends and Consumer Insights
Instore Shopping Report Overview Most consumers in all seven surveyed countries (the US, the UK, Spain, China, Italy, France, and Germany) will continue to shop instore over the next three months. This reflects the persistent importance of physical shops despite the shift to online which was catalyzed by the pandemic in many countries. The highest proportion of instore shopping happens in Spain. This aligns with the country’s relatively low online penetration, with consumers still valuing the instore shopping experience. The...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NTO-1151 in Neuroendocrine Tumors
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NTO-1151 in Neuroendocrine Tumors report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NTO-1151 in Neuroendocrine Tumors Drug Details: Triapine (NTO-1151) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ST-266 in Necrotizing Enterocolitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ST-266 in Necrotizing Enterocolitis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ST-266 in Necrotizing Enterocolitis Drug Details: ST-266 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NTO-1151 in Recurrent Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NTO-1151 in Recurrent Glioblastoma Multiforme (GBM) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NTO-1151 in Recurrent Glioblastoma Multiforme (GBM) Drug Details: Triapine...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Denileukin Diftitox in Sezary Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Denileukin Diftitox in Sezary Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Denileukin Diftitox in Sezary Syndrome Drug Details: Denileukin diftitox (Ontak,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Denileukin Diftitox in Mycosis Fungoides
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Denileukin Diftitox in Mycosis Fungoides report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Denileukin Diftitox in Mycosis Fungoides Drug Details: Denileukin diftitox (Ontak,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Denileukin Diftitox in Cutaneous T-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Denileukin Diftitox in Cutaneous T-Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Denileukin Diftitox in Cutaneous T-Cell Lymphoma Drug Details: Denileukin...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Belimumab in Emphysema
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Belimumab in Emphysema report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Belimumab in Emphysema Drug Details: Belimumab (Benlysta) is a human IgG1 monoclonal...